Sign in Register

Retraction: Corrigendum: Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.

By Frontiers Editorial Office · · 1 min read

Save

The journal retracts the 22 January 2025 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Frontiers would like to thank Sholto David for contacting the journal regarding the published article.

Related articles

PubMed

Dirozalkib versus Crizotinib in Advanced Anaplastic Lymphoma Kinase Inhibitor-Naïve ALK-Positive Non-Small-Cell Lung Cancer: A Multicenter, Randomized Phase III Trial.

Background: Dirozalkib is a highly selective anaplastic lymphoma kinase (ALK) inhibitor with intracranial antitumor activity against crizotinib-resistant mutations. This phase III trial evaluated dirozalkib versus crizotinib in patients with ALK inhibitor-naïve, ALK-positive, advanced non-small-cell lung cancer (NSCLC). Methods: In this multicenter, randomized, open-label DIAMOND-2 trial, adult patients with ALK inhibitor-naïve, ALK-positive, advanced NSCLC who either had received no prior syste...

PubMed

Geometry based gene-expression signatures detect cancer treatment responders in clinical trials.

Background Topological data analysis has had many developments with potential application to precision oncology. The goal of this study is to determine if using geometry-based methods of gene-expression signatures of tumors can be used to both create a definitive classification of responders and non-responders, and to predict patient treatment response using out-of-sample testing methodology. Methods Gene-expression signatures of tumors, constructed from geometrical attributes of data, were c...